TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/18/22 17:34 | 7/14/22 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pierce Glenn | MA | D | S | -64 | 6.70 | 0 | -10 | -30 | 22 | D | |||||||||||||||
6/16/22 18:01 | 6/14/22 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pierce Glenn | CA | D | M.d | 0 | 0.00 | 0 | 4 | 16 | 26 | D | |||||||||||||||
6/21/21 16:24 | 6/17/21 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pierce Glenn | CA | D | M.d | 0 | 0.00 | 0 | 3 | 15 | 23 | D | |||||||||||||||
9/14/20 18:12 | 9/10/20 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pierce Glenn | CA | D | M.d | 225 | 15.03 | 0 | 15 | 313 | 20 | D | |||||||||||||||
6/19/20 21:30 | 6/17/20 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pierce Glenn | CA | D | M.d | 0 | 0.00 | 0 | 5 | New | 5 | D | |||||||||||||||
9/12/18 20:49 | 9/12/18 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pierce Glenn | MA | D | P | 92 | 18.44 | 0 | 5 | New | 5 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |